Press Releases from NSCLC Market (1 total)
The NSCLC Market Will Be Valued At $10.9 Billion In 2021 At A CAGR Of 8.5%
Researchmoz added Most up-to-date research on "Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line" to its huge collection of research reports.
Non-Small Cell Lung Cancer (NSCLC) is the second most common cancer globally, and the most common cause of cancer-related mortality. Such a poor outlook, particularly for patients with advanced disease, has created a pressing need…
